Healthcare provider profile · identity verified

Elisha Ann Payne, CNP

Nurse Practitioner · SOUTH POINT, OH · NPI 1689237166

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	502	48
Levothyroxine Sodium	Levothyroxine Sodium	232	25
Gabapentin	Gabapentin	228	38
Sertraline Hcl	Sertraline Hcl	212	32
Donepezil Hcl	Donepezil Hcl	210	18
Potassium Chloride	Potassium Chloride	189	28
Lisinopril	Lisinopril	185	26
Tramadol Hcl	Tramadol Hcl	166	29
Amlodipine Besylate	Amlodipine Besylate	146	19
Famotidine	Famotidine	140	suppressed
Furosemide	Furosemide	140	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	133	34
Omeprazole	Omeprazole	131	20
Mirtazapine	Mirtazapine	130	16
Metformin Hcl	Metformin Hcl	129	14
Pantoprazole Sodium	Pantoprazole Sodium	120	16
Clopidogrel	Clopidogrel Bisulfate	116	12
Tamsulosin Hcl	Tamsulosin Hcl	112	16
Metoprolol Tartrate	Metoprolol Tartrate	100	17
Trazodone Hcl	Trazodone Hcl	99	14
Lorazepam	Lorazepam	96	19
Losartan Potassium	Losartan Potassium	96	12
Carvedilol	Carvedilol	85	12
Eliquis	Apixaban	83	11
Oxybutynin Chloride Er	Oxybutynin Chloride	82	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	79	suppressed
Duloxetine Hcl	Duloxetine Hcl	76	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	72	suppressed
Metoprolol Succinate	Metoprolol Succinate	68	13
Ezetimibe	Ezetimibe	67	suppressed
Hydralazine Hcl	Hydralazine Hcl	60	suppressed
Montelukast Sodium	Montelukast Sodium	58	suppressed
Buspirone Hcl	Buspirone Hcl	55	suppressed
Simvastatin	Simvastatin	54	suppressed
Oxycodone Hcl	Oxycodone Hcl	51	suppressed
Olanzapine	Olanzapine	50	suppressed
Levetiracetam	Levetiracetam	47	suppressed
Memantine Hcl	Memantine Hcl	47	suppressed
Ondansetron Hcl	Ondansetron Hcl	46	22
Divalproex Sodium	Divalproex Sodium	43	suppressed
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Lactulose	Lactulose	39	suppressed
Trulicity	Dulaglutide	39	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Citalopram Hbr	Citalopram Hydrobromide	35	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	33	14
Pravastatin Sodium	Pravastatin Sodium	33	suppressed
Allopurinol	Allopurinol	32	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	32	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	30	suppressed
Clonazepam	Clonazepam	29	suppressed
Paliperidone Er	Paliperidone	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Invega Sustenna	Paliperidone Palmitate	28	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	26	suppressed
Nystatin	Nystatin	26	14
Ondansetron Odt	Ondansetron	26	suppressed
Entresto	Sacubitril/Valsartan	25	suppressed
Januvia	Sitagliptin Phosphate	25	suppressed
Jardiance	Empagliflozin	25	suppressed
Lubiprostone	Lubiprostone	25	suppressed
Nifedipine Er	Nifedipine	25	suppressed
Risperidone	Risperidone	25	suppressed
Aripiprazole	Aripiprazole	24	suppressed
Lovastatin	Lovastatin	23	suppressed
Amiodarone Hcl	Amiodarone Hcl	22	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Diclofenac Sodium	Diclofenac Sodium	22	11
Ozempic	Semaglutide	22	suppressed
Xarelto	Rivaroxaban	21	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	20	suppressed
Dorzolamide Hcl	Dorzolamide Hcl	20	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Oseltamivir Phosphate	Oseltamivir Phosphate	20	18
Doxycycline Hyclate	Doxycycline Hyclate	19	14
Ramipril	Ramipril	19	suppressed
Benztropine Mesylate	Benztropine Mesylate	18	suppressed
Celecoxib	Celecoxib	18	suppressed
Oxcarbazepine	Oxcarbazepine	18	suppressed
Phenobarbital	Phenobarbital	18	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	18	suppressed
Loperamide	Loperamide Hcl	17	suppressed
Tresiba Flextouch U-100	Insulin Degludec	17	suppressed
Amantadine	Amantadine Hcl	16	suppressed
Diazepam	Diazepam	16	suppressed
Finasteride	Finasteride	16	suppressed
Glimepiride	Glimepiride	16	suppressed
Linzess	Linaclotide	16	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	15	12
Digoxin	Digoxin	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Fenofibrate	Fenofibrate,micronized	15	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	15	suppressed
Mesalamine Dr	Mesalamine	15	suppressed
Spironolactone	Spironolactone	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Tradjenta	Linagliptin	15	suppressed
Alprazolam	Alprazolam	14	suppressed
Colchicine	Colchicine	14	suppressed
Felodipine Er	Felodipine	14	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Glipizide	Glipizide	14	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	14	suppressed
Prednisone	Prednisone	14	suppressed
Sulfasalazine	Sulfasalazine	14	suppressed
Tizanidine Hcl	Tizanidine Hcl	14	suppressed
Valsartan	Valsartan	14	suppressed
Albuterol Sulfate	Albuterol Sulfate	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Comfort Ez Pen Needle	Pen Needle, Diabetic	13	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	13	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	12	suppressed
Gemtesa	Vibegron	12	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	12	suppressed
Temazepam	Temazepam	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Clonidine Hcl	Clonidine Hcl	11	suppressed
Imipramine Hcl	Imipramine Hcl	11	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	11	suppressed
Valacyclovir	Valacyclovir Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error